Cipher Capital’s Core Laboratories CLB Stock Holding History

Cipher Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19,729	Closed	-$391K	–	456
2022 Q2	$391K	Buy	+19,729	New	+$524K	0.09%	267
2020 Q1	–	Sell	-32,698	Closed	-$1.23M	–	415
2019 Q4	$1.23M	Buy	32,698 +10,946	+50%	+$492K	0.09%	281
2019 Q3	$1.01M	Buy	+21,752	New	+$1.01M	0.08%	326
2018 Q1	–	Sell	-17,270	Closed	-$1.89M	–	570
2017 Q4	$1.89M	Buy	17,270 +905	+6%	+$90.3K	0.15%	235
2017 Q3	$1.61M	Buy	+16,365	New	+$1.59M	0.12%	302
2016 Q2	–	Sell	-6,310	Closed	-$709K	–	699
2016 Q1	$709K	Buy	6,310 +66	+1%	+$6.86K	0.07%	462
2015 Q4	$679K	Buy	+6,244	New	+$715K	0.1%	298
2015 Q3	–	Sell	-2,583	Closed	-$295K	–	543
2015 Q2	$295K	Buy	+2,583	New	+$313K	0.04%	411

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Cipher Capital's CLB Position: Q3 2022 in Review

Cipher Capital sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 19,729 shares — an estimated $391K sold.

Cipher Capital first reported a position in CLB in Q2 2015 and held it in 8 quarters. The position peaked at $1.89M in Q4 2017. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

Cipher Capital reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
Cipher Capital sold 19,729 Core Laboratories shares in Q3 2022, an estimated $391K.
Cipher Capital first reported a position in Core Laboratories in Q2 2015 and held it in 8 quarters.
Cipher Capital's Core Laboratories position peaked at $1.89M in Q4 2017.
162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Cipher Capital's 13F filing for Q3 2022, filed 14 Nov 2022.